Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Microorganisms|August 27, 2021
Differences in Gut Virome Related to Barrett Esophagus and Esophageal AdenocarcinomaTianli Ma, Jinlong Ru, Jinling Xue, et al.Gut Microbes|September 25, 2023
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infectionShiqi Luo, Jinlong Ru, Mohammadali Khan Mirzaei, et al.Expert Opinion on Biological Therapy|October 5, 2021
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjectsGuangwen Liu, Zhongnan Xu, Wei Yang, et al.Expert Opinion on Investigational Drugs|February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjectsYanli Wang, Jinling Xue, Zhengjie Su, et al.Expert Review of Clinical Pharmacology|March 8, 2023
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trialZhongnan Xu, Zhengzhi Liu, Yanli Wang, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 21, 2024
Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjectsZhengzhi Liu, Jinling Xue, Qiaohuan Deng, et al.Journal of Cancer Research and Clinical Oncology|June 30, 2022
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjectsGuangwen Liu, Jinling Xue, Yanli Wang, et al.Expert Opinion on Investigational Drugs|April 15, 2022
A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjectsZhongnan Xu, Yanli Wang, Guangwen Liu, et al.Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.Pageof 3